| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Symbotic Inc. (NYSE:SYM) will release earnings results for the fourth quarter, after the closing bell on Monday, Nov. 24.
Analysts expect the Wilmington, Massachusetts-based company to report quarterly earnings of 8 cents per share, down from 47 cents per share in the year-ago period. The consensus estimate for Symbiotic’s quarterly revenue is $604 million. Benzinga Pro data shows $576.77 million in quarterly revenue a year ago.
On Aug. 6, Symbiotic reported a third-quarter EPS miss and issued fourth-quarter sales guidance below estimates.
Shares of Symbotic gained 1.4% to close at $54.72 on Thursday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
Considering buying SYM stock? Here’s what analysts think:

Photo via Shutterstock
Posted In: SYM